{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:30:22Z","timestamp":1793039422575,"version":"4.5.0"},"reference-count":68,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coronavirus disease 2019 pandemic accelerated the implementation of digital technologies, which have now become embedded as essential tools for the management of chronic disease, including cystic fibrosis (CF). Despite subsequent easing of restrictions and because of improved clinical stability resulting from the introduction of highly effective modulator therapy, digital technologies including video and telephone consultations and remote monitoring are likely to remain integral to the future delivery of CF health care. In this article, we explore some of the key developments in digital technologies, barriers to their adoption, and how the CF community is likely to embrace lessons learned from the recent pandemic to help modernize and reshape the future of CF care.<\/jats:p>","DOI":"10.1055\/s-0042-1758730","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T01:12:54Z","timestamp":1671498774000},"page":"217-224","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis"],"prefix":"10.1055","volume":"44","author":[{"given":"Daniel","family":"Peckham","sequence":"additional","affiliation":[{"name":"Leeds Adult Cystic Fibrosis Unit, St James's University Hospital, Leeds, United Kingdom"},{"name":"Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Spoletini","sequence":"additional","affiliation":[{"name":"Leeds Adult Cystic Fibrosis Unit, St James's University Hospital, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1056\/NEJMp2005835","article-title":"Covid-19 and health care's digital revolution","volume":"382","author":"S Keesara","year":"2020","journal-title":"N Engl J Med"},{"key":"ref2","first-page":"8","article-title":"Electronic patient records, past, present and future","volume":"20","author":"D Peckham","year":"2016","journal-title":"Paediatr Respir Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e2021118","DOI":"10.1590\/1984-0462\/2022\/40\/2021118in","article-title":"Telemedicine of patients with cystic fibrosis during the COVID-19 pandemic","volume":"40","author":"R LF Costa","year":"2022","journal-title":"Rev Paul Pediatr"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.jcf.2021.10.010","article-title":"Management of cystic fibrosis during COVID-19: patient reported outcomes based remote follow-up among CF patients in Denmark\u2014a feasibility study","volume":"21","author":"L Rodkj\u00e6r","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"08","key":"ref5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1089\/tmj.2020.0091","article-title":"A feasibility study of urgent implementation of cystic fibrosis multidisciplinary telemedicine clinic in the face of covid-19 pandemic: single-center experience","volume":"26","author":"M Compton","year":"2020","journal-title":"Telemed J E Health"},{"issue":"19","key":"ref6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"P G Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"H GM Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"09","key":"ref8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJMoa2100665","article-title":"Triple therapy for cystic fibrosis Phe508del-gating and -residual function genotypes","volume":"385","author":"P J Barry","year":"2021","journal-title":"N Engl J Med"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jcf.2014.03.002","article-title":"The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit","volume":"13","author":"D Peckham","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"ooab084","DOI":"10.1093\/jamiaopen\/ooab084","article-title":"A natural language processing pipeline to synthesize patient-generated notes toward improving remote care and chronic disease management: a cystic fibrosis case study","volume":"4","author":"S A Hussain","year":"2021","journal-title":"JAMIA Open"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"1600987","DOI":"10.1183\/13993003.00987-2016","article-title":"Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis","volume":"49","author":"H White","year":"2017","journal-title":"Eur Respir J"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jcf.2014.04.009","article-title":"Electronic care records\u2014can they fulfil their promise?","volume":"13","author":"C E Wainwright","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MCP.0b013e3283659f45","article-title":"The impact of medication adherence on lung health outcomes in cystic fibrosis","volume":"19","author":"M N Eakin","year":"2013","journal-title":"Curr Opin Pulm Med"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.09-3074","article-title":"Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers","volume":"140","author":"T Daniels","year":"2011","journal-title":"Chest"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jcf.2012.12.012","article-title":"Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time","volume":"12","author":"R Ball","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"e039587","DOI":"10.1136\/bmjopen-2020-039587","article-title":"Protocol for Project Fizzyo, an analytic longitudinal observational cohort study of physiotherapy for children and young people with cystic fibrosis, with interrupted time-series design","volume":"10","author":"E Raywood","year":"2020","journal-title":"BMJ Open"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40814-020-00739-2","article-title":"Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub","volume":"7","author":"M A Arden","year":"2021","journal-title":"Pilot Feasibility Stud"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.chest.2021.06.039","article-title":"Real-world adherence among adults with cystic fibrosis is low: a retrospective analysis of the CFHealthHub Digital Learning Health System","volume":"160","author":"Z H Hoo","year":"2021","journal-title":"Chest"},{"issue":"07","key":"ref19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1357633X16660646","article-title":"Telehealth clinics increase access to care for adults with cystic fibrosis living in rural and remote Western Australia","volume":"23","author":"J Wood","year":"2017","journal-title":"J Telemed Telecare"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/1357633X16649532","article-title":"The use of telehealth (text messaging and video communications) in patients with cystic fibrosis: a pilot study","volume":"23","author":"M Gur","year":"2017","journal-title":"J Telemed Telecare"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2021.08.034","article-title":"Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs","volume":"20","author":"A H Gifford","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"e001844","DOI":"10.1136\/bmjoq-2022-001844","article-title":"Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting","volume":"11","author":"D Albon","year":"2022","journal-title":"BMJ Open Qual"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S1569-1993(11)60388-3","article-title":"The role of electronic patient records (EPR) in improving service efficiency and clinical performance in a regional adult UK centre","volume":"10","author":"C Etherington","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S1569-1993(22)00313-7","article-title":"Evolving cystic fibrosis care during COVID-19: a single-centre experience","volume":"21","author":"G Spoletini","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"09","key":"ref25","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1513\/AnnalsATS.202012-1484RL","article-title":"Favorable clinician acceptability of telehealth as part of the cystic fibrosis care model during the COVID-19 pandemic","volume":"18","author":"R C Perkins","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2021.09.005","article-title":"Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic","volume":"20","author":"G M Solomon","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"06","key":"ref27","first-page":"832","article-title":"The role of telehealth services in children with cystic fibrosis during coronavirus disease 2019 outbreak","volume":"28","author":"\u00d6F Be\u015fer","year":"2022","journal-title":"Telemed J E Health"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcf.2021.09.018","article-title":"The feasibility of home monitoring of young people with cystic fibrosis: results from CLIMB-CF","volume":"21","author":"C Edmondson","year":"2022","journal-title":"J Cyst Fibros"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"784692","DOI":"10.3389\/fped.2021.784692","article-title":"Patient and provider experience with cystic fibrosis telemedicine clinic","volume":"9","author":"K Hendra","year":"2021","journal-title":"Front Pediatr"},{"issue":"09","key":"ref30","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/ppul.25560","article-title":"Change in CF care during COVID-19 pandemic: single-center experience in a middle-income setting","volume":"56","author":"E Hatziagorou","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1258\/jtt.2011.110705","article-title":"Telehealth in cystic fibrosis: a systematic review","volume":"18","author":"N S Cox","year":"2012","journal-title":"J Telemed Telecare"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pedn.2021.11.006","article-title":"Quality improvement and rapid PDSA cycles to maintain routine surveillance of pulmonary pathogens during the COVID-19 pandemic in a pediatric cystic fibrosis clinic","volume":"63","author":"J L Hamilton","year":"2022","journal-title":"J Pediatr Nurs"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2021.08.035","article-title":"Remote monitoring in telehealth care delivery across the U.S. cystic fibrosis care network","volume":"20","author":"T Ong","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"00249","DOI":"10.1183\/23120541.00249-2021","article-title":"Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres","volume":"7","author":"M S Muhlebach","year":"2021","journal-title":"ERJ Open Res"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1513\/AnnalsATS.202101-087RL","article-title":"Cystic fibrosis respiratory microbiology monitoring during a global pandemic: lessons learned from a shift to telehealth","volume":"19","author":"A N Franciosi","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"07","key":"ref36","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/ppul.25925","article-title":"Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis","volume":"57","author":"D C Bouzek","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2021.08.013","article-title":"A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis","volume":"21","author":"A Paynter","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcf.2021.10.012","article-title":"Quality of home spirometry performance amongst adults with cystic fibrosis","volume":"21","author":"J M Bell","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"e27759","DOI":"10.2196\/27759","article-title":"Web portals for patients with chronic diseases: scoping review of the functional features and theoretical frameworks of telerehabilitation platforms","volume":"24","author":"Y Morimoto","year":"2022","journal-title":"J Med Internet Res"},{"issue":"01","key":"ref40","first-page":"A134","article-title":"Physiotherapist-led online exercise session for people with cystic fibrosis (CF) during the COVID-19 pandemic: a service evaluation","volume":"76","author":"C M Milligan","year":"2021","journal-title":"Thorax"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1357633X19828630","article-title":"The feasibility of online video calling to engage patients with cystic fibrosis in exercise training","volume":"26","author":"O W Tomlinson","year":"2020","journal-title":"J Telemed Telecare"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13102-021-00323-y","article-title":"Feasibility and implementation of a personalized, web-based exercise intervention for people with cystic fibrosis for 1 year","volume":"13","author":"B Hillen","year":"2021","journal-title":"BMC Sports Sci Med Rehabil"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4187\/respcare.01922","article-title":"Assessing exercise capacity using telehealth: a feasibility study in adults with cystic fibrosis","volume":"58","author":"N S Cox","year":"2013","journal-title":"Respir Care"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"e34384","DOI":"10.2196\/34384","article-title":"The impact of wearable technologies in health research: scoping review","volume":"10","author":"S Huhn","year":"2022","journal-title":"JMIR Mhealth Uhealth"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12887-018-1301-x","article-title":"A formative study exploring perceptions of physical activity and physical activity monitoring among children and young people with cystic fibrosis and health care professionals","volume":"18","author":"J Shelley","year":"2018","journal-title":"BMC Pediatr"},{"key":"ref46","first-page":"1","article-title":"Accuracy of the ActivPAL and Fitbit Charge 2 in measuring step count in cystic fibrosis","volume":"8","author":"M Curran","year":"2021","journal-title":"Physiother Theory Pract"},{"issue":"04","key":"ref47","doi-asserted-by":"crossref","first-page":"00006","DOI":"10.1183\/23120541.00006-2019","article-title":"Variable agreement between wearable heart rate monitors during exercise in cystic fibrosis","volume":"5","author":"M Gaynor","year":"2019","journal-title":"ERJ Open Res"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12890-020-01313-5","article-title":"New strategies of physical activity assessment in cystic fibrosis: a pilot study","volume":"20","author":"D Savi","year":"2020","journal-title":"BMC Pulm Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of elexacaftor\/tezacaftor\/ivacaftor in response to mental health side effects in adults with cystic fibrosis","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jcf.2022.05.002","article-title":"The sweat chloride test has lived up to the changes in CF care","volume":"21","author":"T Gonska","year":"2022","journal-title":"J Cyst Fibros"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41746-020-0257-z","article-title":"Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exercise","volume":"3","author":"D H Choi","year":"2020","journal-title":"NPJ Digit Med"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jcf.2018.03.005","article-title":"Sweat test for cystic fibrosis: wearable sweat sensor vs. standard laboratory test","volume":"17","author":"D H Choi","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"14","key":"ref53","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1039\/D1RA07888G","article-title":"Wearable microfluidic-based e-skin sweat sensors","volume":"12","author":"H Tabasum","year":"2022","journal-title":"RSC Advances"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jtherbio.2018.12.019","article-title":"Reliability of a wearable sweat rate monitor and routine sweat analysis techniques under heat stress in females","volume":"79","author":"R Relf","year":"2019","journal-title":"J Therm Biol"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"e16791","DOI":"10.2196\/16791","article-title":"Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses","volume":"22","author":"P Timpel","year":"2020","journal-title":"J Med Internet Res"},{"issue":"04","key":"ref56","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"K J Scully","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"659728","DOI":"10.3389\/fped.2021.659728","article-title":"Continuous glucose monitoring as a valuable tool in the early detection of diabetes related to cystic fibrosis","volume":"9","author":"B Gojsina","year":"2021","journal-title":"Front Pediatr"},{"key":"ref58","first-page":"100282","article-title":"Practical aspects of diabetes technology use: continuous glucose monitors, insulin pumps, and automated insulin delivery systems","volume":"27","author":"B E Marks","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"issue":"01","key":"ref59","first-page":"93","article-title":"Satisfaction and concerns with telemedicine endocrine care of patients with cystic fibrosis","volume":"3","author":"R Ahmed","year":"2022","journal-title":"Telemed Rep"},{"issue":"02","key":"ref60","first-page":"S26","article-title":"Early experience of flash glucose monitoring using the Freestyle Libre System in adults with Cystic Fibrosis-Related Diabetes (CFRD) attending a large regional UK centre","volume":"19","author":"D Shimmin","year":"2000","journal-title":"J Cyst Fibros"},{"issue":"06","key":"ref61","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jcf.2018.05.005","article-title":"Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes","volume":"17","author":"F Frost","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jcf.2021.03.009","article-title":"Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19","volume":"20","author":"D Jaclyn","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12890-021-01500-y","article-title":"A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF","volume":"21","author":"S Thee","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12890-019-0784-z","article-title":"CyFiT telehealth: protocol for a randomised controlled trial of an online outpatient physiotherapy service for children with cystic fibrosis","volume":"19","author":"R L Lang","year":"2019","journal-title":"BMC Pulm Med"},{"key":"ref65","first-page":"17","article-title":"A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis","volume":"16","author":"E F Nash","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcf.2021.09.004","article-title":"Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: a qualitative analysis of interviews with cystic fibrosis care team members","volume":"20","author":"A D Van Citters","year":"2021","journal-title":"J Cyst Fibros"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2021.09.006","article-title":"Telehealth use in cystic fibrosis during COVID-19: association with race, ethnicity, and socioeconomic factors","volume":"20","author":"D Albon","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jcf.2020.06.003","article-title":"In the south, if you give us lemons, we will make you lemonade","volume":"19","author":"B Garcia","year":"2020","journal-title":"J Cyst Fibros"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1758730.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T01:22:41Z","timestamp":1678411361000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1758730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":68,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2023,3,9]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1758730","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]}}}